Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2000

Study Completion Date

January 31, 2004

Conditions
Chronic Myeloproliferative Disorders
Interventions
BIOLOGICAL

filgrastim

DRUG

busulfan

DRUG

cytarabine

DRUG

idarubicin

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (9)

10021

New York Presbyterian Hospital - Cornell Campus, New York

55905

Mayo Clinic Cancer Center, Rochester

60612

University of Illinois College of Medicine, Chicago

63110

Washington University Siteman Cancer Center, St Louis

75475

Hopital Saint-Louis, Paris

99508-4627

Katmai Oncology Group, Anchorage

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

CB2 2QQ

Addenbrooke's NHS Trust, Cambridge

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00006367 - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis | Biotech Hunter | Biotech Hunter